$6M sweet spot round size
Most of their 24 investments are in rounds between $3.5M and $17M
2014
Domain Therapeutics raised $41M on May 10, 2022
Investors: Schroders Capital, 3B Future Health Fund, Theodorus Investment Funds, Omnes, adMare BioInnovations, Seventure Partners and Viva BioInnovator
ArrePath raised $20M on March 3, 2022
Investors: Innospark Ventures, Nor'easter Ventures, Insight Partners, PTX Capital and Viva BioInnovator
Undisclosed raised $5M on February 9, 2022
Investors: Broadview Ventures Inc, Humboldt Fund, 4see ventures, Apollo Ventures and Viva BioInnovator
Amberstone Biosciences raised $12M on January 3, 2022
Investors: 苏州凯风正德投资管理有限公司 and Viva BioInnovator
Fuse Biotherapeutics raised $9.5M on November 15, 2021
Investors: Sirona Capital, 夏尔巴股权投资管理有限公司 and Viva BioInnovator
Deka Biosciences, Inc raised $20M on October 29, 2021
Investors: Lumira Ventures, Leaps by Bayer and Viva BioInnovator
IpiNovyx Bio raised $10M on October 5, 2021
Investors: Pathway Bioventures, Generation Ventures, Lilly Ventures and Viva BioInnovator
Karma Biotechnologies raised $2.8M on September 1, 2021
Investors: Calm Ventures, MarsBio, -, Tuesday Capital, Khosla Ventures, SOSV - The Accelerator VC and Viva BioInnovator
Undisclosed raised $20M on May 20, 2021
Investors: Apollo Ventures, 4see ventures, Broadview Ventures Inc and Viva BioInnovator
Undisclosed raised $18M on May 5, 2021
Investors: 4see ventures, Apollo Ventures, Broadview Ventures Inc and Viva BioInnovator